Theravance Biopharma, Inc. Restricted Cash and Cash Equivalents, Noncurrent
Theravance Biopharma, Inc. (TBPH) had Restricted Cash and Cash Equivalents, Noncurrent of $800.00 thousand as of 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2020-02-27
- 2019-12-31: Restricted Cash and Cash Equivalents, Noncurrent $800.00K.
- 2019-06-30: Restricted Cash and Cash Equivalents, Noncurrent $833.00K.
- 2019-03-31: Restricted Cash and Cash Equivalents, Noncurrent $833.00K.
- 2018-12-31: Restricted Cash and Cash Equivalents, Noncurrent $800.00K; Restricted Cash and Cash Equivalents, Noncurrent as first filed $833.00K.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent | Restricted Cash and Cash Equivalents, Noncurrent as first filed |
|---|---|---|
| 2019-12-31 | $800.00K 10-K · filed 2020-02-27 | |
| 2019-06-30 | $833.00K 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $833.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $800.00K 10-K · filed 2020-02-27 | $833.00K 10-K · filed 2019-02-28 |
| 2018-09-30 | $833.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $833.00K 10-Q · filed 2019-08-05 | |
| 2018-03-31 | $833.00K 10-Q · filed 2019-05-10 | |
| 2017-12-31 | $833.00K 10-K · filed 2019-02-28 | |
| 2017-09-30 | $833.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $833.00K 10-Q · filed 2018-08-02 | |
| 2017-03-31 | $833.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $833.00K 10-K · filed 2018-02-28 | |
| 2016-09-30 | $833.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $833.00K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $833.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $833.00K 10-K · filed 2017-03-01 | |
| 2015-09-30 | $833.00K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $833.00K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $833.00K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $833.00K 10-K · filed 2016-03-11 | |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $833.00K 10-Q · filed 2014-06-24 | |
| 2013-12-31 | $833.00K 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |